![Joseph Truitt](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Joseph Truitt
Presidente presso
LARIMAR THERAPEUTICS, INC.
Patrimonio netto: 9 570 $ in data 31/05/2026
Profilo
Joseph Truitt is Chief Executive Officer & Director at iECURE, Inc. since 2021.
Mr. Truitt is Chairman at Larimar Therapeutics, Inc. since 2020.
Mr. Truitt is Director at Code Biotherapeutics, Inc. since 2020.
Former roles include Chief Executive Officer & Director at BioSpecifics Technologies Corp.
in 2020.
President, Chief Executive Officer & Director at Achillion Pharmaceuticals, Inc. from 2018 to 2020.
Vice President-Sales & Operations at Johnson & Johnson in 2006.
Vice President-Sales & Operations at OraPharma, Inc. in 2002.
VP-Business Development & Product Strategy at Lev Pharmaceuticals, Inc. from 2007 to 2008.
Education includes undergraduate studies at LaSalle University and an MBA from St. Joseph's University.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 19/05/2026 | 2.750 ( 0% ) | 9 570 $ | 31/05/2026 |
Posizioni attive di Joseph Truitt
| Società | Posizione | Inizio |
|---|---|---|
| LARIMAR THERAPEUTICS, INC. | Presidente | 28/05/2020 |
Code Biotherapeutics, Inc.
 Code Biotherapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company | Direttore/Membro del Consiglio | 01/12/2020 |
IEcure, Inc.
 IEcure, Inc. BiotechnologyHealth Technology Operates as a a clinical-stage biotechnology company that develops in-vivo gene insertion/editing therapies to treat rare liver disorders | Amministratore Delegato | 01/03/2021 |
Precedenti posizioni note di Joseph Truitt
| Società | Posizione | Fine |
|---|---|---|
| BIOSPECIFICS TECHNOLOGIES CORP. | Amministratore Delegato | 02/12/2020 |
| ACHILLION PHARMACEUTICALS, INC. | Amministratore Delegato | 28/01/2020 |
Lev Pharmaceuticals, Inc.
 Lev Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapeutic products for the treatment of inflammatory diseases | Corporate Officer/Principal | 01/12/2008 |
| JOHNSON & JOHNSON | Direttore operativo | 01/07/2006 |
OraPharma, Inc.
 OraPharma, Inc. Pharmaceuticals: MajorHealth Technology Develops and produces drugs for oral diseases | Direttore operativo | 01/01/2002 |
Formazione di Joseph Truitt
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
72
Relazioni di 1° grado
10
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 10 |
|---|---|
Johnson & Johnson
 Johnson & Johnson Pharmaceuticals: MajorHealth Technology Operates as an investment holding company with interests in health care products | Health Technology |
BioSpecifics Technologies Corp.
 BioSpecifics Technologies Corp. Pharmaceuticals: MajorHealth Technology Develops injectable collagenase clostridium histolyticum (CCH) for multiple indications | Health Technology |
OraPharma, Inc.
OraPharma, Inc. Pharmaceuticals: MajorHealth Technology Develops and produces drugs for oral diseases | Health Technology |
Achillion Pharmaceuticals, Inc.
 Achillion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes treatments for infectious diseases | Health Technology |
LaSalle University
 LaSalle University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
St. Joseph's University
 St. Joseph's University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Lev Pharmaceuticals, Inc.
Lev Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapeutic products for the treatment of inflammatory diseases | Health Technology |
Larimar Therapeutics, Inc.
 Larimar Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company focused on developing treatments for complex rare diseases | Health Technology |
Code Biotherapeutics, Inc.
Code Biotherapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company | Health Technology |
IEcure, Inc.
IEcure, Inc. BiotechnologyHealth Technology Operates as a a clinical-stage biotechnology company that develops in-vivo gene insertion/editing therapies to treat rare liver disorders | Health Technology |
